{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:11:56Z","timestamp":1790770316935,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31902308"],"award-info":[{"award-number":["31902308"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170154"],"award-info":[{"award-number":["32170154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2019QC010"],"award-info":[{"award-number":["ZR2019QC010"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFC1200500"],"award-info":[{"award-number":["2019YFC1200500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013317","name":"Shanxi Provincial Key Research and Development Project","doi-asserted-by":"publisher","award":["2019GNC106006"],"award-info":[{"award-number":["2019GNC106006"]}],"id":[{"id":"10.13039\/501100013317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Medicine"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.imj.2022.09.003","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T04:33:13Z","timestamp":1663993993000},"page":"262-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Research progress on neutralizing epitopes and antibodies for the Rabies virus"],"prefix":"10.1016","volume":"1","author":[{"given":"Chenjuan","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peilu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lele","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imj.2022.09.003_bib0001","series-title":"WHO Expert Consultation On Rabies: Third Report","year":"2018"},{"issue":"6322","key":"10.1016\/j.imj.2022.09.003_bib0002","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.355.6322.238","article-title":"Taming rabies","volume":"355","author":"Stokstad","year":"2017","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.imj.2022.09.003_bib0003","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.vaccine.2017.03.001","article-title":"Rabies: still a silent killer targeting the poor","volume":"35","author":"Wilde","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.imj.2022.09.003_bib0004","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/S1473-3099(17)30574-1","article-title":"Comparative pathogenesis of rabies in bats and carnivores, and implications for spillover to humans","volume":"18","author":"Begeman","year":"2018","journal-title":"Lancet Infect. Dis."},{"issue":"6","key":"10.1016\/j.imj.2022.09.003_bib0005","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1111\/tbed.13629","article-title":"Rabies viruses in specific wild fur animals in northern China, 2017-2019","volume":"67","author":"Liu","year":"2020","journal-title":"Transbound. Emerg. Dis."},{"issue":"3","key":"10.1016\/j.imj.2022.09.003_bib0006","doi-asserted-by":"crossref","first-page":"e2097","DOI":"10.1371\/journal.pntd.0002097","article-title":"Isolation of Irkut virus from a Murina leucogaster bat in China","volume":"7","author":"Liu","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"4","key":"10.1016\/j.imj.2022.09.003_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/v12040368","article-title":"Rabies in the African Civet: an incidental host for Lyssaviruses?","volume":"12","author":"Sabeta","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.imj.2022.09.003_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2020.105787","article-title":"Rabies control in Liberia: joint efforts towards zero by 30","volume":"216","author":"Voupawoe","year":"2021","journal-title":"Acta Trop."},{"issue":"5","key":"10.1016\/j.imj.2022.09.003_bib0009","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1473-3099(11)70340-1","article-title":"Passive immunity in the prevention of rabies","volume":"12","author":"Both","year":"2012","journal-title":"Lancet Infect. Dis."},{"issue":"4","key":"10.1016\/j.imj.2022.09.003_bib0010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cvsm.2019.02.014","article-title":"Rabies: current preventive strategies","volume":"49","author":"Moore","year":"2019","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"issue":"3","key":"10.1016\/j.imj.2022.09.003_bib0011","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/cid\/cix791","article-title":"Comparison of a novel human rabies monoclonal antibody to human rabies immunoglobulin for postexposure prophylaxis: a phase 2\/3, randomized, single-blind, noninferiority, controlled study","volume":"66","author":"Gogtay","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.imj.2022.09.003_bib0012","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1099\/jgv.0.000998","article-title":"Antigenic site changes in the rabies virus glycoprotein dictates functionality and neutralizing capability against divergent lyssaviruses","volume":"99","author":"Evans","year":"2018","journal-title":"J. Gen. Virol."},{"issue":"9951","key":"10.1016\/j.imj.2022.09.003_bib0013","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(13)62707-5","article-title":"Current status of rabies and prospects for elimination","volume":"384","author":"Fooks","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.imj.2022.09.003_bib0014","doi-asserted-by":"crossref","first-page":"884","DOI":"10.2460\/javma.233.6.884","article-title":"Rabies surveillance in the United States during 2007","volume":"233","author":"Blanton","year":"2008","journal-title":"J. Am. Vet. Med. Assoc."},{"issue":"52","key":"10.1016\/j.imj.2022.09.003_bib0015","doi-asserted-by":"crossref","first-page":"7447","DOI":"10.1016\/j.vaccine.2012.10.015","article-title":"Rabies virus vaccines: is there a need for a pan-lyssavirus vaccine?","volume":"30","author":"Evans","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.imj.2022.09.003_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/v13010069","article-title":"Genetic and antigenetic characterization of the novel Kotalahti Bat Lyssavirus (KBLV)","volume":"13","author":"Calvelage","year":"2021","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.imj.2022.09.003_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/v13040576","article-title":"Lagos bat virus, an under-reported rabies-related Lyssavirus","volume":"13","author":"Coertse","year":"2021","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.imj.2022.09.003_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/v13102064","article-title":"Spillover of West Caucasian Bat Lyssavirus (WCBV) in a domestic cat and westward expansion in the Palearctic region","volume":"13","author":"Leopardi","year":"2021","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.imj.2022.09.003_bib0019","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/zph.12519","article-title":"Bokeloh bat lyssavirus isolation in a Natterer's bat, Poland","volume":"65","author":"Smreczak","year":"2018","journal-title":"Zoonoses Public Health"},{"issue":"32","key":"10.1016\/j.imj.2022.09.003_bib0020","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1016\/j.vaccine.2005.03.037","article-title":"Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses","volume":"23","author":"Brookes","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.imj.2022.09.003_bib0021","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virusres.2005.03.009","article-title":"Efficacy of rabies biologics against new lyssaviruses from Eurasia","volume":"111","author":"Hanlon","year":"2005","journal-title":"Virus Res."},{"issue":"1","key":"10.1016\/j.imj.2022.09.003_bib0022","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13028-017-0332-x","article-title":"Efficacy of rabies vaccines in dogs and cats and protection in a mouse model against European bat lyssavirus type 2","volume":"59","author":"Nokireki","year":"2017","journal-title":"Acta Vet. Scand."},{"issue":"Pt 8","key":"10.1016\/j.imj.2022.09.003_bib0023","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1099\/vir.0.065953-0","article-title":"Comparative studies on the genetic, antigenic and pathogenic characteristics of Bokeloh bat lyssavirus","volume":"95","author":"Nolden","year":"2014","journal-title":"J. Gen. Virol."},{"issue":"5838","key":"10.1016\/j.imj.2022.09.003_bib0024","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/294275a0","article-title":"Structure of the glycoprotein gene in rabies virus","volume":"294","author":"Anilionis","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.imj.2022.09.003_bib0025","article-title":"Change in the single amino acid site 83 in rabies virus glycoprotein enhances the BBB permeability and reduces viral pathogenicity","volume":"8","author":"Li","year":"2020","journal-title":"Front. Cell. Dev. Biol"},{"issue":"3","key":"10.1016\/j.imj.2022.09.003_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/v11030218","article-title":"Deficient incorporation of rabies virus glycoprotein into virions enhances virus-induced immune evasion and viral pathogenicity","volume":"11","author":"Li","year":"2019","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.imj.2022.09.003_bib0027","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1073\/pnas.1618883114","article-title":"Mechanism of membrane fusion induced by vesicular stomatitis virus G protein","volume":"114","author":"Kim","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A.,"},{"issue":"3","key":"10.1016\/j.imj.2022.09.003_bib0028","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.chom.2019.12.012","article-title":"Structural analysis of rabies virus glycoprotein reveals ph-dependent conformational changes and interactions with a neutralizing antibody","volume":"27","author":"Yang","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.imj.2022.09.003_bib0029","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/bs.aivir.2019.05.003","article-title":"Structural and cellular biology of rhabdovirus entry","volume":"104","author":"Belot","year":"2019","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.imj.2022.09.003_bib0030","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1099\/0022-1317-83-6-1465","article-title":"Rabies virus glycoprotein can fold in two alternative, antigenically distinct conformations depending on membrane-anchor type","volume":"83","author":"Maillard","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"6","key":"10.1016\/j.imj.2022.09.003_bib0031","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0092-8674(00)81072-7","article-title":"Budding of rabies virus particles in the absence of the spike glycoprotein","volume":"84","author":"Mebatsion","year":"1996","journal-title":"Cell"},{"issue":"Pt 1","key":"10.1016\/j.imj.2022.09.003_bib0032","first-page":"119","article-title":"Mapping of epitopes and structural analysis of antigenic sites in the nucleoprotein of rabies virus","volume":"81","author":"Goto","year":"2000","journal-title":"J. Gen. Virol."},{"issue":"8","key":"10.1016\/j.imj.2022.09.003_bib0033","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00705-010-0709-x","article-title":"Characterization of conformation-specific monoclonal antibodies against rabies virus nucleoprotein","volume":"155","author":"Jiang","year":"2010","journal-title":"Arch. Virol."},{"issue":"5","key":"10.1016\/j.imj.2022.09.003_bib0034","doi-asserted-by":"crossref","first-page":"724","DOI":"10.14202\/vetworld.2019.724-728","article-title":"Antigenic site of nucleoprotein gene from Indonesian rabies virus isolates","volume":"12","author":"Rahmahani","year":"2019","journal-title":"Vet World"},{"issue":"4","key":"10.1016\/j.imj.2022.09.003_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/v11040375","article-title":"Generation of monoclonal antibodies against variable epitopes of the M protein of rabies virus","volume":"11","author":"Liu","year":"2019","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.imj.2022.09.003_bib0036","doi-asserted-by":"crossref","DOI":"10.3390\/v13020220","article-title":"Development of monoclonal antibodies for detection of conserved and variable epitopes of large protein of rabies virus","volume":"13","author":"Zhao","year":"2021","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.imj.2022.09.003_bib0037","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/abbs\/gmv060","article-title":"Viral suppression function of intracellular antibody against C-terminal domain of rabies virus phosphoprotein","volume":"47","author":"Liu","year":"2015","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"issue":"4","key":"10.1016\/j.imj.2022.09.003_bib0038","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1128\/JCM.38.4.1397-1403.2000","article-title":"A panel of monoclonal antibodies targeting the rabies virus phosphoprotein identifies a highly variable epitope of value for sensitive strain discrimination","volume":"38","author":"Nadin-Davis","year":"2000","journal-title":"J. Clin. Microbiol."},{"issue":"Pt 12","key":"10.1016\/j.imj.2022.09.003_bib0039","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1099\/0022-1317-83-12-3035","article-title":"Structural relationship between nucleocapsid-binding activity of the rabies virus phosphoprotein (P) and exposure of epitope 402-13 located at the C terminus","volume":"83","author":"Toriumi","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"8","key":"10.1016\/j.imj.2022.09.003_bib0040","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1128\/JVI.79.8.4672-4678.2005","article-title":"Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis","volume":"79","author":"Marissen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.imj.2022.09.003_bib0041","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.virusres.2016.04.019","article-title":"Characterization of epitopes on the rabies virus glycoprotein by selection and analysis of escape mutants","volume":"220","author":"Fallahi","year":"2016","journal-title":"Virus Res."},{"issue":"1","key":"10.1016\/j.imj.2022.09.003_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/jvi.62.1.1-7.1988","article-title":"Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence","volume":"62","author":"Prehaud","year":"1988","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.imj.2022.09.003_bib0043","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00253-012-4171-4","article-title":"Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein","volume":"96","author":"Sun","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.imj.2022.09.003_bib0044","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/652147","article-title":"Generation and characterization of an scFv directed against Site II of rabies glycoprotein","volume":"2011","author":"Aavula","year":"2011","journal-title":"Biotechnol. Res. Int."},{"issue":"3","key":"10.1016\/j.imj.2022.09.003_bib0045","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/jvi.53.3.926-934.1985","article-title":"Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein","volume":"53","author":"Seif","year":"1985","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.imj.2022.09.003_bib0046","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0042-6822(89)90122-0","article-title":"Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice","volume":"172","author":"Tuffereau","year":"1989","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.imj.2022.09.003_bib0047","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1128\/JVI.72.1.273-278.1998","article-title":"An avirulent mutant of rabies virus is unable to infect motoneurons in vivo and in vitro","volume":"72","author":"Coulon","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.imj.2022.09.003_bib0048","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1099\/0022-1317-70-2-291","article-title":"Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein","author":"Bunschoten","year":"1989","journal-title":"J. Gen. Virol."},{"issue":"8","key":"10.1016\/j.imj.2022.09.003_bib0049","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1128\/jvi.64.8.3804-3809.1990","article-title":"Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine","volume":"64","author":"Dietzschold","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.imj.2022.09.003_bib0050","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1099\/0022-1317-74-8-1539","article-title":"Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein","author":"van der Heijden","year":"1993","journal-title":"J. Gen. Virol."},{"issue":"12\u201313","key":"10.1016\/j.imj.2022.09.003_bib0051","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.micinf.2010.06.005","article-title":"Fine mapping and interaction analysis of a linear rabies virus neutralizing epitope","volume":"12","author":"Cai","year":"2010","journal-title":"Microbes Infect."},{"issue":"8","key":"10.1016\/j.imj.2022.09.003_bib0052","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1128\/jvi.65.8.4198-4203.1991","article-title":"Antigenicity of rabies virus glycoprotein","volume":"65","author":"Benmansour","year":"1991","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.imj.2022.09.003_bib0053","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0168-1702(97)00080-4","article-title":"A virus-neutralizing epitope on the glycoprotein of rabies virus that contains Trp251 is a linear epitope","volume":"51","author":"Luo","year":"1997","journal-title":"Virus Res."},{"issue":"1\u20132","key":"10.1016\/j.imj.2022.09.003_bib0054","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.virusres.2013.02.013","article-title":"Identification of rabies virus mimotopes screened from a phage display peptide library with purified dog anti-rabies virus serum IgG","volume":"174","author":"Yang","year":"2013","journal-title":"Virus Res."},{"key":"10.1016\/j.imj.2022.09.003_bib0055","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1099\/vir.0.80362-0","article-title":"Identification of a conserved linear epitope at the N terminus of the rabies virus glycoprotein","volume":"85","author":"Mansfield","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.imj.2022.09.003_bib0056","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.virol.2016.08.034","article-title":"The Lyssavirus glycoprotein: a key to cross-immunity","volume":"498","author":"Buthelezi","year":"2016","journal-title":"Virology"},{"issue":"Pt 4","key":"10.1016\/j.imj.2022.09.003_bib0057","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1099\/0022-1317-64-4-843","article-title":"Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies","volume":"64","author":"Lafon","year":"1983","journal-title":"J. Gen. Virol."},{"issue":"3","key":"10.1016\/j.imj.2022.09.003_bib0058","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008383","article-title":"Crystal structure of Mokola virus glycoprotein in its post-fusion conformation","volume":"16","author":"Belot","year":"2020","journal-title":"PLoS Pathog."},{"issue":"12","key":"10.1016\/j.imj.2022.09.003_bib0059","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/nbt1363","article-title":"The growth and potential of human antiviral monoclonal antibody therapeutics","volume":"25","author":"Marasco","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"4676","key":"10.1016\/j.imj.2022.09.003_bib0060","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1126\/science.6494916","article-title":"Amino acid sequence similarity between rabies virus glycoprotein and snake venom curaremimetic neurotoxins","volume":"226","author":"Lentz","year":"1984","journal-title":"ScienceScience"},{"key":"10.1016\/j.imj.2022.09.003_bib0061","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev.ph.57.030195.002513","article-title":"Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons","volume":"57","author":"McGehee","year":"1995","journal-title":"Annu. Rev. Physiol."},{"issue":"9","key":"10.1016\/j.imj.2022.09.003_bib0062","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1128\/JVI.72.9.7181-7190.1998","article-title":"The neural cell adhesion molecule is a receptor for rabies virus","volume":"72","author":"Thoulouze","year":"1998","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.imj.2022.09.003_bib0063","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/infdis\/jiy081","article-title":"The Role of Heparan Sulfate Proteoglycans as an Attachment Factor for Rabies Virus Entry and Infection","volume":"217","author":"Sasaki","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imj.2022.09.003_bib0064","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1099\/vir.0.81063-0","article-title":"Stable trimerization of recombinant rabies virus glycoprotein ectodomain is required for interaction with the p75NTR receptor","volume":"86","author":"Sisso\u00ebff","year":"2005","journal-title":"J. Gen. Virol."},{"issue":"24","key":"10.1016\/j.imj.2022.09.003_bib0065","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.1093\/emboj\/17.24.7250","article-title":"Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus","volume":"17","author":"Tuffereau","year":"1998","journal-title":"EMBO J."},{"issue":"8","key":"10.1016\/j.imj.2022.09.003_bib0066","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004348","article-title":"Rabies Virus Hijacks and accelerates the p75NTR retrograde axonal transport machinery","volume":"10","author":"Gluska","year":"2014","journal-title":"PLoS Pathog."},{"issue":"21","key":"10.1016\/j.imj.2022.09.003_bib0067","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1128\/JVI.76.21.10756-10765.2002","article-title":"Mutations conferring resistance to neutralization by a soluble form of the neurotrophin receptor (p75NTR) map outside of the known antigenic sites of the rabies virus glycoprotein","volume":"76","author":"Langevin","year":"2002","journal-title":"J. Virol."},{"issue":"24","key":"10.1016\/j.imj.2022.09.003_bib0068","doi-asserted-by":"crossref","first-page":"13622","DOI":"10.1128\/JVI.02368-06","article-title":"The rabies virus glycoprotein receptor p75NTR is not essential for rabies virus infection","volume":"81","author":"Tuffereau","year":"2007","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.imj.2022.09.003_bib0069","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007189","article-title":"Metabotropic glutamate receptor subtype 2 is a cellular receptor for rabies virus","volume":"14","author":"Wang","year":"2018","journal-title":"PLoS Pathog."},{"issue":"21","key":"10.1016\/j.imj.2022.09.003_bib0070","doi-asserted-by":"crossref","first-page":"11637","DOI":"10.1128\/JVI.01648-13","article-title":"Uptake of rabies virus into epithelial cells by clathrin-mediated endocytosis depends upon actin","volume":"87","author":"Piccinotti","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.imj.2022.09.003_bib0071","first-page":"121","article-title":"Interactions of viral proteins with neurotransmitter receptors may protect or destroy neurons","volume":"253","author":"Gosztonyi","year":"2001","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.imj.2022.09.003_bib0072","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0042-6822(91)90145-2","article-title":"Spread of the CVS strain of rabies virus and of the avirulent mutant AvO1 along the olfactory pathways of the mouse after intranasal inoculation","volume":"183","author":"Lafay","year":"1991","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.imj.2022.09.003_bib0073","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/13550280590900427","article-title":"Rabies virus receptors","volume":"11","author":"Lafon","year":"2005","journal-title":"J. Neurovirol."},{"issue":"1","key":"10.1016\/j.imj.2022.09.003_bib0074","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41467-020-14398-7","article-title":"Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein","volume":"11","author":"Hellert","year":"2020","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.imj.2022.09.003_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256779","article-title":"A broad-spectrum and highly potent human monoclonal antibody cocktail for rabies prophylaxis","volume":"16","author":"Kim","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.imj.2022.09.003_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2022.102267","article-title":"Efficacy of ormutivimab, a novel recombinant human anti-rabies monoclonal antibody, in post-exposure prophylaxis animal models","volume":"46","author":"Zhai","year":"2022","journal-title":"Travel. Med. Infect. Dis."},{"key":"10.1016\/j.imj.2022.09.003_bib0077","series-title":"WHO Expert Consultation On Rabies: Second Report","year":"2013"},{"issue":"2","key":"10.1016\/j.imj.2022.09.003_bib0078","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-1702(03)00217-X","article-title":"Bat lyssaviruses (Aravan and Khujand) from Central Asia: phylogenetic relationships according to N, P and G gene sequences","volume":"97","author":"Kuzmin","year":"2003","journal-title":"Virus Res."},{"issue":"10","key":"10.1016\/j.imj.2022.09.003_bib0079","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109367","article-title":"Protective effect of different anti-rabies virus VHH constructs against rabies disease in mice","volume":"9","author":"Terryn","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.imj.2022.09.003_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006133","article-title":"SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies","volume":"11","author":"Chao","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.imj.2022.09.003_bib0081","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/375247","article-title":"Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies","volume":"188","author":"Prosniak","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.imj.2022.09.003_bib0082","first-page":"399","article-title":"[Development of recombinant human monoclonal antibody cocktail for post-exposure rabies prophylaxis]","volume":"32","author":"Sun","year":"2016","journal-title":"Chin. J. Virol."},{"key":"10.1016\/j.imj.2022.09.003_bib0083","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.molimm.2018.07.003","article-title":"Comparison of rabies virus protection by single chain and leucine zipper Fv fragments cocktail derived from a monoclonal antibody cocktail","volume":"101","author":"Xi","year":"2018","journal-title":"Mol. Immunol."},{"issue":"11","key":"10.1016\/j.imj.2022.09.003_bib0084","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1371\/journal.pntd.0000542","article-title":"Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans","volume":"3","author":"M\u00fcller","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.imj.2022.09.003_bib0085","article-title":"A phase 3, randomised, open-label, non-inferiority trial evaluating anti-rabies monoclonal antibody cocktail (TwinrabTM) against human rabies immunoglobulin (HRIG)","author":"Kansagra","year":"2020","journal-title":"Clin. Infect. Dis"},{"issue":"6","key":"10.1016\/j.imj.2022.09.003_bib0086","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/500470","article-title":"Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin","volume":"193","author":"Goudsmit","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"47","key":"10.1016\/j.imj.2022.09.003_bib0087","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1016\/j.vaccine.2008.08.050","article-title":"First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity","volume":"26","author":"Bakker","year":"2008","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.imj.2022.09.003_bib0088","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1016\/j.vaccine.2013.09.038","article-title":"Alanine scanning of the rabies virus glycoprotein antigenic site III using recombinant rabies virus: implication for post-exposure treatment","volume":"31","author":"Papaneri","year":"2013","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.imj.2022.09.003_bib0089","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1128\/JVI.79.14.9062-9068.2005","article-title":"Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants","volume":"79","author":"Bakker","year":"2005","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.imj.2022.09.003_bib0090","doi-asserted-by":"crossref","first-page":"407","DOI":"10.15252\/emmm.201505986","article-title":"Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis","volume":"8","author":"De Benedictis","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"11","key":"10.1016\/j.imj.2022.09.003_bib0091","doi-asserted-by":"crossref","first-page":"e12628","DOI":"10.15252\/emmm.202012628","article-title":"A combination of two human monoclonal antibodies cures symptomatic rabies","volume":"12","author":"de Melo","year":"2020","journal-title":"EMBO Mol. Med."},{"issue":"4","key":"10.1016\/j.imj.2022.09.003_bib0092","doi-asserted-by":"crossref","first-page":"e17665","DOI":"10.1371\/journal.pone.0017665","article-title":"Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules","volume":"6","author":"Hultberg","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.imj.2022.09.003_bib0093","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004902","article-title":"Post-exposure treatment with anti-rabies VHH and vaccine significantly improves protection of mice from lethal rabies infection","volume":"10","author":"Terryn","year":"2016","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Infectious Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772431X22000429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772431X22000429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T10:45:12Z","timestamp":1757414712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772431X22000429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":93,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2772431X22000429"],"URL":"https:\/\/doi.org\/10.1016\/j.imj.2022.09.003","relation":{},"ISSN":["2772-431X"],"issn-type":[{"value":"2772-431X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research progress on neutralizing epitopes and antibodies for the Rabies virus","name":"articletitle","label":"Article Title"},{"value":"Infectious Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imj.2022.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of Tsinghua University Press.","name":"copyright","label":"Copyright"}]}}